Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

U.S. Futures Mixed; Vaccine News Helps Balance Treasury/Fed Spat

Published 2020-11-20, 07:13 a/m
© Reuters.
EUR/USD
-
XAU/USD
-
US500
-
DJI
-
PFE
-
GC
-
LCO
-
ESZ24
-
CL
-
1YMZ24
-
NQZ24
-
IXIC
-
FL
-

By Peter Nurse   

Investing.com - U.S. stocks are seen opening mixed Friday, with investors having to digest fresh restrictions as Covid-19 cases rise, tensions between the Treasury and the Federal Reserve as well as more positive vaccine news and renewed fiscal stimulus talks.

At 7:15 AM ET (1215 GMT), the Dow Futures contract fell 27 points, or 0.1%, while S&P 500 Futures traded flat, and Nasdaq 100 Futures was up 27 points, or 0.2%. 

The Dow Jones Industrial Average and the S&P 500 indices are near breakeven for the week, but the Dow is currently on course for its best month since 1987 and the S&P 500 for its best since April. The Nasdaq Composite is heading for its second up week in three.

The U.S. set a new single-day record of 185,000 new Covid-19 cases Thursday, with the number of patients hospitalized jumping nearly 50% in the last two weeks, prompting states to impose new restrictions to try and curb the spread.

California Governor Gavin Newsom on Thursday ordered a 10 PM. curfew in the most populated U.S. state, starting Saturday, while the Center for Disease Control urged Americans not to travel over the Thanksgiving holiday.

Also weighing on sentiment was a disagreement between the Treasury Department and the Federal Reserve over whether some of the emergency programs implemented to support the economy during the recession still need to be funded. 

This contrasted with news that Republican Majority Leader Mitch McConnell had agreed to revive talks to craft a new fiscal relief package.

Helping the tone Friday was Pfizer (NYSE:PFE) announcing it would be applying to the U.S. FDA later today for emergency use authorization of its Covid-19 vaccine, which it is developing in conjunction with German BioNTech. The pharma giant said it could start shipping the vaccine as soon as it received approval.

Both the earnings and economic data slates are quiet Friday, with quarterly numbers from Foot Locker (NYSE:FL) the only release of note.

Oil prices edged higher Friday, continuing a largely positive week despite concerns about demand growth given the growing number of coronavirus cases and signs of a slowdown in the U.S. labor market. 

U.S. crude futures traded 0.2% higher at $41.97 a barrel, while the international benchmark Brent contract rose 0.4% to $44.37, both remaining well above the $40 mark after the gains earlier in the week on the back of vaccine optimism.

Elsewhere, gold futures rose 0.1% to $1,863.95/oz, while EUR/USD traded 0.1% lower at 1.1869.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.